Detalles de la búsqueda
1.
Biomarkers for response to TIL therapy: a comprehensive review.
J Immunother Cancer
; 12(3)2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485186
2.
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.
J Immunother Cancer
; 12(3)2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531663
3.
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
J Immunother Cancer
; 12(5)2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38782542
4.
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37604641
5.
Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab.
J Immunother Cancer
; 11(5)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217243
6.
Pre-existing TGF-ß-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948507
7.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586765
8.
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis.
J Immunother Cancer
; 10(9)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096534
9.
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
J Immunother Cancer
; 10(10)2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316062
Resultados
1 -
9
de 9
1
Próxima >
>>